David H Aggen, Assistant Attending at Memorial Sloan Kettering Cancer Center, shared a post on X:
“I recently highlighted several key developments in muscle-invasive bladder cancer—innovations that are already shaping clinical practice and paving the way for future breakthroughs.
We remain committed to accelerating research that improves outcomes for all patients facing bladder cancer, funded in part by by the vital contributions of Cycle4Survival the movement to fund rare cancer research.
We are proud to be riding again this year to help drive progress for patients.”
Donate for rare cancer research.
More posts featuring David H Aggen.